Cellyrix Therapeutics

Private

IsraelHealthcare & Life Scienceshttps://cellyrix.com/

Last Round

Seed

Dec 1, 2024

Company Overview

Cellyrix Therapeutics is a biotechnology company that leverages single-cell RNA sequencing and artificial intelligence to develop innovative cancer therapies targeting tumor heterogeneity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverysingle-cell RNA sequencingcell-state modulationoncology therapeuticsAI drug discoveryprecision medicinetumor heterogeneitycomputational biologyAI-driven biotechscRNA-seqin silico drug discoverybiotech platformtherapeutic developmentAI-first biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellyrix Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Cellyrix Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellyrix Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Dec 1, 2024

View all Funding Rounds

Cellyrix Therapeutics Investors

Notable investors and investment history

Cellyrix Therapeutics investors
Investor	Rounds
Israel Biotech Fund	Seed
Amiti Ventures	Seed
AION Labs	Seed

View all Investors

Cellyrix Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cellyrix Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellyrix Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael

Year Founded2024

Last FundingDec 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.